DOWNINGTOWN, Pa., May 27, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of the Friedreich’s Ataxia Research Alliance (FARA) today announced the hiring of Barbara Tate, Ph.D. to the full-time role of ...

Thought LeadersDr. Lauren MooreChief Scientific OfficerNational Ataxia Foundation (NAF) In this interview, we speak to Dr. Lauren Moore from the National Ataxia Foundation about ataxia and how the NFL ...

A new mechanism that worsens the symptoms of cerebellar ataxia, a rare degenerative cerebellar disease, has been identified.

Ataxia telangiectasia (A‐T) is a rare autosomal recessive disorder that manifests with progressive neurodegeneration, immunodeficiency, oncogenic predisposition and heightened radiosensitivity.

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. This study lends support to the theory that Friedreich's ataxia (FRDA) affects certain ...

TOPEKA, Kan. (WIBW) - What started as a class project turned into much more. The assignment was to work with a nonprofit for six hours. Maxwell Guth decided to turn it into something larger. “So we ...

PLANO, Texas--(BUSINESS WIRE)--Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Skyclarys, Reata Pharmaceuticals’ oral, once-daily medication to treat Friedreich’s ataxia ...

Regina McKenzie, CEO of Get It Done Solutions, shared her personal and heartfelt journey as a caregiver for her mother, diagnosed with Spinocerebellar Ataxia in 2012. During the segment, she ...